Health Economics›Nasopharyngeal carcinoma›Locally advanced disease definitive chemoradiotherapy

Locally advanced disease definitive chemoradiotherapy

Nasopharyngeal carcinoma · 6 regimens

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

Filters

Y-axis

Cost vs Efficacy

No data points — cost or PFS missing for current selection.

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
Oxaliplatin and RT Variant #01	—	R 4 516	42d	—	—	—	—	1
Cisplatin and Fluorouracil (CF) and RT Variant #13	—	R 1 850	28d	—	~16.5 mo	—	—	1
Carboplatin and RT Variant #01	—	R 1 516	42d	—	~22.4 mo	—	—	1
Cisplatin and RT Variant #01	—	R 1 500	49d	—	—	—	—	3
Radiation therapy N/A - radiation Partial	—	—	49d	—	—	—	—	3
Nedaplatin and RT Variant #01 Partial	—	—	—	~30.0 mo	—	—	—	1

6 of 6 regimens shown